Dow AgroSciences and Arcadia Biosciences Developing, Commercializing Improved Wheat Quality Trait
August 08 2017 - 8:00AM
Business Wire
Combined Expertise to Accelerate Development
and Commercialization of New Crop Trait Focused on Improved
Nutrition
Arcadia Biosciences, Inc. (Nasdaq: RKDA) and Dow AgroSciences
LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE:
DOW), today announced a collaboration to jointly develop and
commercialize a breakthrough improved wheat quality trait in North
America. The collaboration leverages Arcadia’s leading non-GM
TILLING trait development platform with Dow AgroSciences’ enabling
technology platforms, high-quality elite germplasm and global
commercial channels.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170808005223/en/
Under the collaboration, the companies will further develop and
commercialize an improved wheat quality trait, which has completed
initial field trials and is advancing to next-stage field trials.
Dow AgroSciences will introgress Arcadia’s trait into its
proprietary elite germplasm lines and manage all aspects related to
the trait commercialization. Certain development costs will be
co-funded under the collaboration agreement, and the commercial
value will be shared by Arcadia and Dow AgroSciences.
“Wheat is a staple crop around the globe, and our scientific
expertise can help improve the nutritional profile and quality of
this important crop by enhancing its value for human health and
consumption while also enabling farmers to produce an added value
crop,” said Rolando Alegria, global business leader, wheat, forages
and sorghum, Dow AgroSciences.
“This collaboration reflects the unique nature of Arcadia’s
business model, expanding our access into the growing market of
improved nutrition traits with an established leader in
agriculture,” said Raj Ketkar, president and CEO of Arcadia
Biosciences. “Dow AgroSciences’ experience in value-added crops is
a perfect complement to Arcadia’s portfolio of nutritional quality
traits. Together, we can accelerate the development and commercial
deployment of improved nutrition crop traits to deliver significant
added value to growers, food manufacturers and consumers.”
Specific financial and trait details of the collaboration were
not disclosed.
About Arcadia Biosciences, Inc.
Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA)
develops agricultural products that create added value for farmers
while benefitting the environment and enhancing human health.
Arcadia’s agronomic performance traits, including Nitrogen Use
Efficiency, Water Use Efficiency, Salinity Tolerance, Heat
Tolerance and Herbicide Tolerance, are all aimed at making
agricultural production more economically efficient and
environmentally sound. Arcadia’s nutrition traits and products are
aimed at creating healthier ingredients and whole foods with lower
production costs. For more information, visit
www.arcadiabio.com.
About Dow AgroSciences
Dow AgroSciences discovers, develops, and brings to market crop
protection and plant biotechnology solutions for the growing world.
Based in Indianapolis, Indiana, USA, Dow AgroSciences is a wholly
owned subsidiary of The Dow Chemical Company and had annual global
sales of $6.2 billion in 2016. Learn more at www.dowagro.com.
Follow Dow AgroSciences on Facebook, Twitter, LinkedIn, and
Google+, or subscribe to our News Release RSS Feed.
®™Trademark of The Dow Chemical Company (“Dow”) or an affiliated
company of Dow.
Note Regarding Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995, including statements relating to Arcadia’s
strategic partnership with Dow AgroSciences to develop and
commercialize agricultural traits. Forward-looking statements are
subject to risks and uncertainties that could cause actual results
to differ materially, and reported results should not be considered
as an indication of future performance. These risks and
uncertainties include, but are not limited to: Arcadia’s and its
partners’ and affiliates’ ability to develop commercial products
incorporating its traits, including healthy grain traits, and
complete the regulatory review process for such products; Arcadia’s
compliance with laws and regulations that impact the company’s
business, and changes to such laws and regulations; Arcadia’s
future capital requirements and ability to satisfy its capital
needs; and the other risks set forth in Arcadia’s filings with the
Securities and Exchange Commission from time to time, including the
risks set forth in Arcadia’s annual report on Form 10K for the year
ended December 31, 2016 and other filings. These forward-looking
statements speak only as of the date hereof, and Arcadia
Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170808005223/en/
Arcadia BiosciencesJeff Bergau,
312-217-0419jeff.bergau@arcadiabio.comorDow
AgroSciencesKenda Resler Friend,
317-337-4743kresler@dow.com
Dow (NYSE:DOW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dow (NYSE:DOW)
Historical Stock Chart
From Apr 2023 to Apr 2024